Keyword: Novo Nordisk


Novo Holdings to Acquire Catalent for $16.5 Billion

08.02.2024 -

Novo Holdings, Novo Nordisk's parent company, is acquiring US contract development and manufacturing organization (CDMO) Catalent for $16.5 billion. The companies said...


Novo Nordisk to Invest €2.1 Billion in French Production Site

24.11.2023 -

Novo Nordisk wants to make another major capital investment in production capacity for its diabetes and obesity therapies. The Danish drugmaker announced to spend more...


Novo Nordisk to Invest €5.6 Billion in Expansion of API Production in Denmark

13.11.2023 -

Danish drugmaker Novo Nordisk plans to invest more than 42 billion Danish kroner (about €5.6 billion) starting in 2023 to expand existing manufacturing facilities at the...


Novo Nordisk to Buy Hypertension Treatment from KBP Biosciences

18.10.2023 -

Novo Nordisk has agreed to acquire ocedurenone for uncontrolled hypertension with potential application in cardiovascular and kidney disease from KBP Biosciences for up...


Novo Holdings, Gurnet Point Close Acquisition of Paratek Pharmaceuticals

25.09.2023 -

Novo Holdings, controlling shareholder in drugmaker Novo Nordisk, and healthcare investment firm Gurnet Point closed their acquisition of US antibiotics specialist...


Novo Nordisk to Acquire Inversago Pharma

11.08.2023 -

Danish drugmaker Novo Nordisk has agreed to acquire Montreal, Canada-based Inversago Pharma. The transaction is worth up to $1.075 billion in cash if certain development...


Novo Nordisk in Talks to Take Majority Stake in Biocorp

07.06.2023 -

Danish drugmaker Novo Nordisk is in exclusive talks to take a controlling stake in Biocorp, a French company specializing in developing and producing delivery systems and...

Markets & Companies

Navigating Uncertainty in the Biopharma Market

17.05.2023 -

Biopharma companies are facing funding challenges in 2023 as interest rates rise and investors are becoming more risk adverse. There is hope on the horizon, say some...